• English
  • Español

Selecting and interpreting data from relevant studies of adverse effects

Topic category Other methods for preparing systematic reviews
Date and Location
Date: 
Thursday 20 October 2011 - 14:00 - 15:30
Location: 
Methods Group
Methods Group: 
Adverse Effects Methods Group
Contact person
Contact person: 
Su Golder (Contact this person)
Facilitators
First nameLast nameAffiliation and Country
First name: 
Christine
Last name: 
Schmucker
Affiliation and Country: 
German Cochrane Centre
First name: 
Andrew
Last name: 
Herxheimer
Affiliation and Country: 
Adverse Effects Methods Group, UK
First name: 
Su
Last name: 
Golder
Affiliation and Country: 
Adverse Effects Methods Group, UK
First name: 
Denise
Last name: 
Adams
Affiliation and Country: 
Adverse Effects Methods Group, Canada
Other contributors
First nameLast nameAffiliation and Country
First name: 
Yoon
Last name: 
Loke
Affiliation and Country: 
Adverse Effects Methods Group, UK
Target audience
Target audience: 
all
Is your workshop restricted to a specific audience or open to all Colloquium participants?: 
Open
Level of knowledge required: 
Any
Type of workshop
Type of workshop: 
Training
Abstract text
Abstract: 
Objective:
This workshop focuses on how to incorporate adverse effects into systematic reviews, in particular the selection of appropriate study designs relevant to the review objective and nature of the adverse effect.

Description:
Most review authors are well-versed with studies of effectiveness, but may be less conversant with the diverse range of study designs used in assessing the safety of an intervention. We intend to highlight some of the methodological differences, and provide practical guidance on devising inclusion and exclusion criteria for study selection in systematic reviews of adverse effects. This will involve giving a number of scenarios to participants, who will then work together in small groups to plan a protocol for study selection in evaluating adverse effects. The scenarios will be drawn from real-life situations to cover a wide range of potential adverse effects.
At the end, groups will feedback on their protocols, and any points raised will be discussed further.